Therapeutic Area Head, Late-Stage Oncology, GU and Melanoma

About the role

The Genitourinary and Melanoma Vice President is responsible and accountable for the overarching late-stage development plan for our company's assets in these disease areas. The VP will also be responsible and accountable for the end-to-end lifecycle management of selected assets. The VP will lead their teams to optimize development of assets for the treatment of specific disease areas that they oversee.

Responsibilities

• Lead the Genitourinary (GU) and Melanoma Clinical Research groups and act as the Therapeutic Area Head for mid to late-stage clinical development for these disease areas.
• Lead programs for selected assets from early-stage transition into late-stage design/execution for GU malignancies and melanoma.
• In addition, the VP will be responsible for the end-to-end lifecycle management for selected assets with a GU or melanoma focus that also could have potential across several diseases.
• Create, develop and implement a successful disease area strategy that will bring forth programs to successful approval, registration and access for the selected indications.
• Ensure clinical programs and clinical studies are designed and monitored optimally.
• Ensure that team documents (protocols, governance documents, regulatory documents, external communications, publications, etc) are of the highest quality.
• Interface with functional leaders within Research and Development (R&D) (e.g., Discovery, Translational Biomarkers, GCTO, BARDS, GRACS, TPharm), CORE, Global Human Health, and Manufacturing to ensure optimal decision-making and operational excellence in the leadership of teams.
• Builds relationships with and gains insights from scientific leaders and key stakeholders in a dynamic and thoughtful way.
• Contributes to business development by identifying and assessing new assets and leads clinical activities and strategy for assets under consideration.

Requirements

• M.D., with significant expertise in Medical Oncology, with at least 15 years of relevant academic and/or industry experience including building and leading effective teams.
• Adult oncology specialty training (oncology fellowship or equivalent) is preferred.
• A recognized expert in specialty & clinical research, demonstrating depth and breadth of knowledge and understanding of scientific, medical, and regulatory environments, practices and requirements.
• Skilled in leveraging your expert knowledge for scientific, technical, clinical and regulatory strategic thinking, problem solving and decision making in the evolving pharmaceutical environment.
• Demonstrated ability to lead and inspire teams and allocate resource strategically and according to portfolio priorities, attracting, retaining, engaging and developing talent in your groups.
• Energized by delivering high standards through collaboration and motivating others across the organization.
• Experience with leading regulatory submissions, new trial designs and health authority interactions, development of multiple assets with differing MOAs.
• The leader should have a track record of and passion for developing individuals for both in-role technical skills as well as overall career development.
• For selected partnered compounds, the VP serves as our company's senior representative on joint development committees with partners.
• The VP should keep abreast of changing scientific and therapeutic advances, working with discovery/research; early development and business development to ensure identification and movement of key assets for the selected disease areas.